MetaVia announces preclinical findings for DA-1726 waist reduction
MetaVia said preclinical findings support the biological rationale for DA-1726 reducing waist circumference.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
MetaVia said preclinical findings support the biological rationale for DA-1726 reducing waist circumference.